ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future

DURHAM, N.C.--(BUSINESS WIRE)--Aug 4, 2026--

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, announced the launch of “Do It For Future You,” a new multichannel campaign designed to inspire individuals to take control of their health today to better safeguard their future. The campaign encourages discussions between individuals and their health providers about long-acting injectable HIV prevention and treatment options. The campaign uses one clear message: the choices you make today shape your tomorrow.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260730209757/en/

Despite scientific progress transforming HIV from a debilitating and fatal illness into a manageable chronic condition, the epidemic persists, with more than 39,000 U.S. diagnoses annually. 1 Critical gaps in connection to care remain: only about 25% of people who could benefit from pre-exposure prophylaxis (PrEP), a medication that can prevent HIV in people who are HIV-negative, are currently taking it, 2 and nearly a third of people living with HIV in the U.S. (31%) have not yet achieved viral suppression, which threatens their health and allows for further transmission of HIV. 1

Long-acting injectable (LAI) options could help to close these gaps and have been shown to improve adherence and persistence in HIV medicine, leading to continuous viral suppression or protection from HIV. This not only helps to improve long-term individual health outcomes but also helps to reduce transmission, contributing to protecting broader public health. 3,4,5,6,7,8,9,10,11,12,13,14,15

“Do It For Future You” is brought to life through a series of interconnected, relatable stories, anchored by a new website ( ForFutureU.com ). The campaign's hero film calls on individuals to prioritize their wellness and take action: “Do it for the you who’s still becoming... The future doesn’t begin someday. It begins right now. With what you do next. With a conversation. A question. A choice you can feel good about.”

“Our goal with ‘Do It For Future You’ is to help people see that the health decisions they make now shape the life they are building, regardless of their HIV status,” said Bithiah Lafontant, Head of Enterprise Communications at ViiV Healthcare. “We believe long-acting injectables are key to building healthy futures because having different treatment and prevention options can help ensure that no one is left behind. For individuals who may find a daily routine challenging, or where persistent stigma creates a barrier to care, long-acting options offer another way to stay consistent, making a thriving, healthy future feel truly within reach.”

“As a trusted community partner and leader of innovation in long-acting HIV prevention and treatment, ViiV Healthcare believes that having a choice in your medicine is essential,” Lafontant added. “By expanding the options available, people can manage their health in a way that actually fits their lives. Whether it’s starting PrEP, beginning treatment, or reconnecting to care, every one of those decisions is a powerful act of self-care and a confident step towards a promising future.”

With more options available than ever before, ViiV Healthcare wants people to walk into their doctor’s appointments prepared with the right questions about dosing, administration, and what to expect from their medicine.

Lafontant continued, “We want people to understand the simple message of this campaign: Your future belongs to you, not HIV. Take control of your sexual health today by asking the right questions and visiting ForFutureU.com to explore resources for talking with your health provider about long-acting injectable HIV prevention and treatment options, and make the choice that best fits your life.”

About ViiV Healthcare

ViiV Healthcare is a global specialist HIV company established in November 2009 with GSK (LSE: GSK) and Shionogi as current shareholders. The company is dedicated to delivering advances in treatment and care for people living with HIV and for people who could benefit from HIV prevention. ViiV Healthcare’s aims are to take a deeper and broader interest in HIV and AIDS than any company has done before and take a new approach to deliver effective and innovative medicines for HIV treatment and prevention, as well as support communities affected by HIV.

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.

Cautionary statement regarding forward-looking statements

GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the “Risk Factors” section in GSK’s Annual Report on Form 20-F for 2025, and GSK’s Q2 Results for 2026.

References:

1. Centers for Disease Control and Prevention. National HIV prevention and care objectives, 2026. Published 2026. Accessed. https://www.cdc.gov/hiv-data/nhss/national-hiv-prevention-and-care-objectives-2026.html.

2. Centers for Disease Control and Prevention. Core indicators for monitoring the Zeroing In on HIV (ZIH) initiative. HIV Surveillance Data Tables. 2023;4(1). Published August 2023. https://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-4-no-1/index.html.

3. Hickey MD, Gistand N, Grochowski J, Mayorga-Munoz F, Imbert E, Szumowski JD, Oskarsson J, Shiels M, Dilworth S, Appa A, Havlir DV, Gandhi M, Christopoulos K. Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia. Clin Infect Dis. 2025 Apr 30;80(4):864-870.

4. Garris C, et al. Real-world adherence and persistence with long-acting cabotegravir plus rilpivirine (CAB+RPV LA) compared to oral antiretroviral therapy (ART) among people with HIV (PWH) in the U.S.: the ABOVE Study. Open Forum Infectious Diseases 2023 (10; Suppl. 2):ofad500.055, https://doi.org/10.1093/ofid/ofad500.055.

5. Christopoulos KA, et al. First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic. Clin Infect Dis. 2023 Feb 8;76(3):e6-e651.

6. Smith GHR, et al. Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study. Open Forum Infect Dis. 2021 Aug 25;8(9):ofab439.

7. Orkin C, et al. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study. Lancet HIV. 2021 Apr;8(4):e185-e196.

8. Gandhi M, et al. Demonstration project of long-acting antiretroviral therapy in a diverse population of people with HIV. Ann Intern Med 2023;176(7):969-974.

9. Jonsson-Oldenbüttel C, et al. 12-Month Outcomes of Cabotegravir Plus Rilpivirine Long-Acting Every 2 Months in a Real-World Setting: Effectiveness, Adherence to Injections, and Patient-Reported Outcomes From People With HIV-1 in the German CARLOS Study. 25th International AIDS Conference; July 22–26, 2024; Munich, Germany: Poster TUPEB095. https://viivexchange.com/content/dam/cf-viiv/viivexchange/medical/pdf/aids-2024-jonsson-oldenb%C3%BCttel-carlos-12m-clin-effect-tupeb095-final-disc.pdf.

10. Hsu RK, et al. Real-world effectiveness of cabotegravir + rilpivirine vs standard of care oral regimens in the U.S. CROI 2024, Denver, CO, USA: Poster 623. https://www.croiconference.org/wp-content/uploads/sites/2/posters/2024/623.pdf.

11. Eron JR, et al. Real-world utilization of cabotegravir + rilpivirine in the U.S.: data from Trio health cohort. CROI 2024, Denver, CO, USA: Poster 625. https://www.croiconference.org/wp-content/uploads/sites/2/posters/2024/625.pdf.

12. Dandachi D, et al. Clinical outcomes and perspectives of people with human immunodeficiency virus type 1 twelve months after initiation of long-acting cabotegravir and rilpivirine in an observational real-world U.S. study (BEYOND). Open Forum Infect Dis. 2025 Apr 19;12(5):ofaf220.

13. Hastie E, Hill L, Bamford L, Karim A, Martin TCS. Long-acting injectable HIV therapy outcomes among persons with HIV who have adherence challenges to oral antiretroviral therapy. Clin Infect Dis. 2025 Mar 17:ciaf120. doi: 10.1093/cid/ciaf120.

14. Parker B, et al. Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling study. PLoS One. 2021;16(2):e02955.

15. Barda B, et al. Efficacy of long-acting cabotegravir plus rilpivirine in viraemic people living with HIV: A systematic review and meta-analysis. HIV Med 2025;26(7):993-1003.

ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future

ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future

ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future

Russia and Ukraine traded accusations Tuesday that each side’s attacks caused civilian deaths, with officials in the Moscow region saying five people were killed there while authorities in Ukraine said a similar number, including two children, died at various sites across the country.

Russia has relentlessly pounded civilian areas of Ukraine, even though Moscow insists its forces target only military facilities.

Since the Kremlin launched its full-scale invasion over four years ago, Ukraine has developed long-range drones that can strike deep inside Russia. In the past year, its forces have battered oil facilities, major storage depots and other key infrastructure.

More than 16,000 civilians have been killed in Ukraine since the war began, the United Nations said last month in its most recent casualty report, with the vast majority occurring in areas under the Ukrainian government’s control. Casualties have risen steadily each year.

The U.N. children’s agency on Tuesday urged both countries to uphold international humanitarian law requiring the protection of children, citing recent deaths in Russia's Belgorod and Krasnodar regions, as well as in Ukraine's Dnipropetrovsk and Sumy regions.

“Attacks that kill and injure children must stop,” UNICEF said in a statement.

Meanwhile, escalating attacks on shipping in the Black Sea by both sides has reawakened fears that global food security could be put at risk.

Ukrainian President Volodymyr Zelenskyy posted a video on social media that he said showed a Russian drone hunting a man selling vegetables from a street stall in the southern city of Kherson.

The video shows the man trying to flee the drone as it circles his vehicle, follows him and ultimately strikes the car where he was trying to hide. He suffered wounds to his back, legs and arms, according to an interview he gave to the Kherson regional military administration.

Russia's Defense Ministry did not immediately reply to an Associated Press request for comment.

Drone attacks on civilians have surged since the war began, with 967 people killed, including 10 children, and nearly 7,000 people injured, Ukraine’s Prosecutor General’s Office said Tuesday.

Russian drone operators track and strike civilians going about daily activities, according to previous AP reporting. A U.N. commission concluded in October 2025 that such attacks amounted to crimes against humanity.

“The world must see this,” Zelenskyy said. “It must see every piece of evidence that Russia has gone mad and that its soldiers take pleasure in killing and abusing civilians.”

The death toll from a drone strike Monday in the Russian Black Sea resort of Arkhipo-Osipovka rose to seven, including four children, regional authorities said.

On Tuesday, Krasnodar regional authorities updated the number of wounded to 58, with 21 hospitalized.

Video circulating online showed a drone slamming into a crowded beach with what sounded like gunfire in the background. Ukraine has not commented on the strike.

A Ukrainian drone attack Tuesday in the region around Moscow killed five people and wounded 10 others, said Gov. Andrei Vorobyov. Most of the damage occurred in the Chekhov municipal district, where several fires erupted at the Novoselki industrial zone, he said.

In the latest in a series of attacks attack on Russia’s biggest online retailer Wildberries, the company said its warehouse in the Leningrad region, adjacent to St. Petersburg, was on fire.

In the village of Emmaus, located between Moscow and St. Petersburg, drone debris partially damaged a wall of a Wildberries warehouse, regional Gov. Vitaly Korolyov said.

In the past 18 days, Ukrainian drones have targeted 15 Wildberries warehouses, 13 of which caught fire, said Robert Brovdi, commander of Ukraine’s Unmanned Systems Forces. Ukrainian officials say the company provides goods that can be used by the military. Kyiv is also keen to unsettle the Russian public with high-profile attacks.

The Russian Defense Ministry said its forces on Monday night struck “Ukrainian ports, vessels and port infrastructure” used by Kyiv’s army.

In the port of Chornomorsk, in Ukraine’s southern Odesa region, Russia said it hit an automobile components plant and a port terminal, where the military vehicles were being repaired and ammunition and fuel were being stored.

In the southern port of Mykolaiv, a bulk carrier with military cargo was damaged, while in Pivdennyi, another Ukrainian port, a vessel unloading military cargo was hit, according to the Russian statement.

The ministry also said two bulk carriers hauling weapons and military equipment were damaged at sea, south of Odesa.

Turkey on Tuesday repeated its appeal for both countries to ensure safe passage in the Black Sea after two Turkish-owned ships were attacked by drones after leaving the Russian port of Novorossiysk.

A Turkish Foreign Ministry statement expressed concerns that the war is increasingly spreading across the Black Sea, threatening merchant shipping, and warned such incidents could have broader consequences, including for the global food supply, as important shipments of grain, fertilizer and other key products move through those waters.

Russian attacks on Mykolaiv, including its port, killed an 89-year-old woman and wounded seven other people aged between 2 and 83, Ukrainian regional officials said.

The Russian strike on civilian infrastructure in southern Odesa region destroyed a private home and wounded two people, according to Oleh Kiper, head of the regional military administration.

In Ukraine’s northern Sumy region, six Russian glide bombs killed two girls aged 5 and 10 and an elderly woman, said Oleh Hryhorov, head of the Sumy regional military administration.

Russian forces also struck Kharkiv and 18 towns and villages across the northern region in the previous 24 hours, killing one person and injuring seven, including an 8-year-old, said Oleh Syniehubov, head of the Kharkiv regional military administration.

Strikes in Balakliia, also in the Kharkiv region, damaged an apartment building, a library, three stores and more than 10 houses, wounding two women, local authorities said.

Two glide bombs struck Kramatorsk in the eastern Donetsk region of Ukraine, injuring 24 people, local officials said. Kramatorsk sits at the northern end of Ukraine’s Fortress Belt, where Western analysts say Russia is making a renewed effort to break through after four years of attrition.

Vadym Filashkin, head of the regional military administration, urged people still living near the front to evacuate, saying authorities would help with transportation, housing and other support.

——

Edith M. Lederer at the United Nations contributed.

Follow the AP’s coverage of the war in Ukraine at https://apnews.com/hub/russia-ukraine

In this photo provided by the Ukrainian Emergency Service, private houses destroyed following a night Russian missile attack are seen in Odesa region, Ukraine, Tuesday, Aug. 4, 2026. (Ukrainian Emergency Service via AP)

In this photo provided by the Ukrainian Emergency Service, a firefighter puts out a fire following a Russian missile attack in Dnipropetrovsk region, Ukraine, Tuesday, Aug. 4, 2026. (Ukrainian Emergency Service via AP)